<div class="container-fluid visualization">
  <div class="summary-nav" style="color: white;position: absolute;width:200px;height:100%;background-color:rgb(16, 59, 108);"> 
    <aside>
      <ul class="nav">
        <li class="active" >
          <a ui-sref="dashboard.summary"><i class="fa fa-bars"></i>&nbsp; Summary
          </a>
        </li>
        <li>
          <a ui-sref="dashboard.trackweekly({tabName: ''})">Track Weekly
            <i class="fa fa-chevron-right pull-right" aria-hidden="true"></i>
            <span style="background-color: #10cfbd"></span>
          </a>
        </li>
        <li>
          <a ui-sref="dashboard.trackspecial({tabName: ''})"> Track Special
            <i class="fa fa-chevron-right pull-right" aria-hidden="true"></i>
            <span style="background-color: #6d5cae"></span>
          </a>
        </li>
        <li>
          <a ui-sref="dashboard.tracksocial({tabName: ''})">Track Social
            <i class="fa fa-chevron-right pull-right" aria-hidden="true"></i>
            <span style="background-color: #327fc5"></span>
          </a>
        </li>
        <li>
          <a ui-sref="dashboard.reports({tabName: ''})">Reports
            <i class="fa fa-chevron-right pull-right" aria-hidden="true"></i>
            <span style="background-color: #f7911e"></span>
          </a>
        </li>
      </ul>
    </aside>
  </div>

  <div class="summary-tabs" style="padding: 0 0 0 210px;">
  <div class="widget-row">
    <div class="widget" style="min-height: 340px">
      <div class="widget-content">
        <div class="widget-title">
          <div class="enrollment summary"></div> 
          <a ui-sref="dashboard.trackweekly({tabName: ''})">
           KEY NEWS & COMPETITOR ALERTS <i class="arrow teal pull-right" ></i>
          </a>
        </div>
        <div class="widget-body">

          <div class="dec-bar">
            <div style="background-color: #10cfbd"></div>
          </div>
          <div class="row">
              <div class="key-widget col-md-6"> 
                <div class="small-widget">
                  <div class="small-widget-title">
                    AACE/ACE Publish 2017 T2DM Treatment Algorithm
                  </div>
                  <div class="small-widget-body">
                    <ul>
                       <li>
                           The GLP-1RA class remains recommended above SGLT-2i and DPP-IVi
                       </li>
                       <li>
                           Liraglutide and empagliflozin have both been called out for a possible benefit in CHF, ASCVD, and renal outcomes
                       </li>
                    </ul>
                    <br> 
                    <p>
                      <a class="pull-right">Link</a>
                    </p>
                  </div>
                </div>
                <div class="small-widget">
                  <div class="small-widget-title">
                   JPM Healthcare Conference Day 1 and 2 Coverage
                  </div>
                  <div class="small-widget-body">
                    <ul>
                      <li>
                        The GLP-1RA class remains recommended above SGLT-2i and DPP-IVi  
                      </li>
                      <li>
                        Liraglutide and empagliflozin have both been called out for a possible benefit in CHF, ASCVD, and renal outcomes
                      </li>
                    </ul>
                    <p>
                      <a class="pull-right">Link</a>
                    </p>
                  </div>
                </div>
                <div class="small-widget">
                  <div class="small-widget-title">
                    Sanofi has announced Soliqua 100/33 is now available in US pharmacies
                  </div>
                  <div class="small-widget-body">
                      <ul>
                        <li>
                          Soliqua is a fixed-ration combination of Lantus and lixisenatide indicated for treatment of adults with T2DM who are inadequately controlled on basal insulin or lixisenatide
                        </li>
                      </ul>
                      <br> 
                    <p>
                      <a class="pull-right">Link</a>
                    </p>
                  </div>
                </div>
                <a class="pull-right">Click for more</a>
              </div>
              <div class="key-widget-2 col-md-6">
                <div class="small-widget">
                  <div class="small-widget-title">
                    Canagliflozin (CANVAS) trial
                  </div>
                  <div class="small-widget-body">
                   <ul>
                    <li>
                    A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of JNJ-28431754 on Cardiovascular Outcomes in Adult Subjects with Type 2 Diabetes Mellitus
                    </li>
                   </ul>
                     <br> 
                    <p>
                        <a class="pull-right">Link</a>
                    </p>
                  </div>
                </div>
                <div class="small-widget">
                  <div class="small-widget-title">
                    Graph Here
                  </div>
                  <div class="small-widget-body">
                       <br> 
                       <a class="pull-right">Link</a>
                    </p>
                  </div>
                </div>
                <div class="small-widget">
                  <div class="small-widget-title">
                    Dapagliflozin (DERIVE) trial
                  </div>
                  <div class="small-widget-body">
                    
                    <ul>
                        <li>
                          A Multicenter, Double-Blind, Placebo-Controlled, Parallel Group, Randomized, Phase III Study to Evaluate the Glycemic Efficacy and Renal Safety of Dapagliflozin in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment (CKD 3A) Who Have Inadequate Glycemic Contro
                        </li>
                    </ul>
                    <br> 
                    <p>
                       <a class="pull-right">Link</a>
                    </p>
                  </div>
                </div>
                <a class="pull-right">Click for more</a>
              </div>
          </div>
        </div>
      </div>
    </div>

    <div class="widget" style=" height: 525px">
      <div class="widget-content">
        <div class="widget-title">
          <div class="claims summary"></div>
          <a ui-sref="dashboard.tracksocial({tabName: ''})">
            SOCIAL PULSE <i class="arrow violet pull-right" aria-hidden="true"></i>
          </a>
        </div>
        <div class="widget-body">

          <div class="dec-bar">
            <div style="background-color: #6d5cae"></div>
          </div>
          <table width="100%" height="30%"  class="table table-condensed">
            <thead>
              <tr>
                <th style="text-align: left"></th>
                <th>Overall Buzz</th>
                <th># of shares/retweets</th>
                <th>Mentions in target websites/ forums</th>
                <th>Sentiment</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td>Intarcia</td>
                <td class="text-center" >19</td>
                <td class="text-center" >0</td>
                <td class="text-center" >8
                   
                </td>
                <td></td>
              </tr>
              <tr>
                <td>Jardiance</td>
                <td class="text-center" >65</td>
                <td class="text-center" >320</td>
                <td class="text-center" >45
                </td>
                <td></td>
              </tr>
              <tr>
                <td>Invokana</td>
                <td class="text-center" >86</td>
                <td class="text-center" >432</td>
                <td class="text-center">52
                </td>
                <td></td>
              </tr>
              <tr>
                <td>Janumet</td>
                <td class="text-center" >66</td>
                <td class="text-center" >467</td>
                <td class="text-center">52
                </td>
                <td></td>
              </tr>
            </tbody>
          </table>
          <a class="pull-right">click for more</a>
          <br>
        </div>
      </div>
    </div>
  </div>

  <div class="widget-row last-row">
    <div class="widget" style=" min-height: 140px">
      <div class="widget-content">
        <div class="widget-title">
          <div class="summary centersofvalue"></div> 
          <a ui-sref="dashboard.tracksocial({tabName: ''})">
            TRENDING TOPICS <i class="arrow blue  pull-right" aria-hidden="true"></i>
          </a>
        </div>
        <div class="widget-body">

          <div class="dec-bar">
            <div style="background-color: #327fc5"></div>
          </div>
          <img src="/img/word.png" height:200 width:540/>
          <p>
          <a class="pull-right">Explore More</a>
          </p>
          <br>
        </div>
      </div>
    </div>

    <div class="widget" style="min-height: 140px">
      <div class="widget-content">
        <div class="widget-title">
          <div class="summary healthrisk"></div> 
          <a ui-sref="dashboard.reports({tabName: ''})">
            NEW REPORTS ADDED <i class="arrow yellow pull-right" aria-hidden="true"></i>
          </a>
        </div>
        <div class="widget-body" style="height:282px">

          <div class="dec-bar">
            <div style="background-color: #f7911e;"></div>
          </div>
          <table width="100%" class="table table-condensed">
            <tbody>
              <tr>
                <td>Novo Granted Orphan Status for Ph2 T1DM Anti-IL-21 + Victoza</td>
                <td class="text-right">
                     <a class="pull-right" href="http://176.9.181.46/track/NovoGrantedOrphanStatusforPh2T1DMAnti-IL-21Victoza.docx">Download</a></td>
              </tr>
              <tr>
                <td>Adocia Initiates Two New Projects for Treatment of T1DM</td>
                <td class="text-right">
                   <a class="pull-right" href="http://176.9.181.46/track/AdociaInitiatesTwoNewProjectsforTreatmentofT1DM.docx">Download</a>
                </td>
              </tr> 
            </tbody>
          </table>
          <a class="pull-right">Access All Documents</a>
          <br>
        </div>
      </div>
    </div>
  </div>

   
  </div>
  </div>
</div>
